- Did you mean
- tla vaccines
Search results - 718 results
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
I Desombere; Kevin K. Ariën; Maria Goossens Source: PLOS Global Public Health, Volume 2, Issue 12 (2022) Keywords: COVID-19; fractional dose; reduced dose; mRNA vaccination; non-inferiority; SARS-CoV-2 Abstract: ...
The consistency approach for the substitution of in vivo testing for the quality control of established vaccines: practical considerations and progressive vision
Publication Type: Peer reviewed scientific article Authors: L. Tesolin; J.-F. Dierick; Wim Van Molle Source: Open Research Europe (2022) Keywords: human vaccines in vitro testing in vivo testing ...
Immunogenicity and one-year boostability of a 3-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-Centre clinical trial.
immunoglobulins (RIG) after exposure is still recommended regardless of prior vaccination, due to a lack of data. We aimed to assess the one-year boostability of a 3-dose rabies pre-exposure prophylaxis (PrEP) ...
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
Publication Type: Peer reviewed scientific article Authors: Patrick M Meyer Sauteur; Victoria J Chalker; Berger, Christoph; Nir-Paz, Ran; Michael L Beeton; ESGMAC and the ESGMAC–MyCOVID study group Source: Lancet Microbe, Volume 3, Issue 12 (2022) Keyword ...
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.
residents (NHR) and staff have been disproportionally affected by the COVID-19 pandemic and were therefore prioritised in the COVID-19 vaccination strategy. However, frail older adults, like NHR, are known to ...
Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data.
expertise and therapeutic strategies, vaccination coverage and natural immunity, pressure on the healthcare system, affected population groups) according to the successive waves of COVID-19, dominated by ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Marc; Peter A van Dam Source: Clin Cancer Res (2022) Abstract: PURPOSE: Cancer patients display reduced humoral responses after double-dose COVID-19 vaccination while their cellular response is more ...
Discrepancies between validated GC‐FID and UHPLC‐DAD methods for the analysis of Δ‐9‐THC and CBD in dried hemp flowers
Analysis, Volume 14, Issue 10 (2022) Keywords: agricultural hemp GC-FID herbal product for smoking UHPLC-DAD Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of ...
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
prevalence, incidence and longevity of antibodies against SARS-CoV-2 both after natural infection and after vaccination. RESULTS: Among all participants, 67% were women and 77% GP s. Median age was 43 years. ...
Relative response factors and multiple regression models in liquid chromatography to quantify low-dosed components using alternative standards-proof of concept: total Δ9-THC content in cannabis flowers using CBD as reference.
Publication Type: Peer reviewed scientific article Authors: Cedric De Leersnijder; Céline Duchateau; De Braekeleer, Kris; Eric Deconinck Source: Anal Bioanal Chem, Volume 414, Issue 22 (2022) Keywords: Cannabinoids cannabis Chromatography, Liquid Dronabin ...